de Carvalho Hessel Dias, V. M.Tuon, F.de Jesus Capelo, P.Telles, J. P.Fortaleza, C. M.C.B. [UNESP]Pellegrino Baena, C.2022-04-282022-04-282022-02-01Journal of Hospital Infection, v. 120, p. 43-47.1532-29390195-6701http://hdl.handle.net/11449/223090The incidence density trend of the carbapenem-resistant Gram-negative bacteria was analysed in device-associated infections and antimicrobial consumption in 99 critical care facilities in a low/middle-income country, between January 2019 and December 2020. Carbapenem-resistant Acinetobacter baumannii (CRAB) per 1000 patient-days increased in 2020 and this finding had a strong positive correlation with the incidence density of COVID-19 by the Spearman test. Polymyxin consumption also increased in 2020 but without significant correlation with CRAB or COVID-19 incidence density, presumably due to empirical and untargeted prescribing as a consequence of concern about CRAB infections. These findings are a warning to infection control programmes and antimicrobial stewardship.43-47engAcinetobacter baumanniiAntimicrobial drug resistanceCarbapenemsCOVID-19Healthcare-associated infectionsPolymyxinsArtigo10.1016/j.jhin.2021.11.0112-s2.0-85121565937